Glucose control system with automated backup therapy protocol generation
AssigneeBeta Bionics, Inc.
InventorsEdward B. Raskin, David Chi-Wai Lim, Michael J. Rosinko, Firas H. El-Khatib, Edward R. Damiano
Life of this patent
Estimating the term…
Loading patent…
AssigneeBeta Bionics, Inc.
InventorsEdward B. Raskin, David Chi-Wai Lim, Michael J. Rosinko, Firas H. El-Khatib, Edward R. Damiano
Estimating the term…
An automated blood glucose control system is configured to generate a backup therapy protocol comprising insulin therapy instructions derived from autonomously determined doses of insulin. The system generates a dose control signal using a control algorithm configured to autonomously determine doses of insulin to be infused into a subject for the purpose of controlling blood glucose of the subject based at least in part on a glucose level signal received from a glucose sensor. The system can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject as basal insulin, as correction boluses of insulin, or as mealtime boluses of insulin. The system can generate a backup injection therapy protocol or a backup pump therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.
An automated glucose level control system configured to generate a backup therapy protocol comprising insulin therapy dosing recommendations derived from autonomously determined doses of insulin, the automated glucose level control system comprising:
A computer-implemented method of generating a backup therapy protocol comprising insulin therapy dosing recommendations derived from autonomously determined doses of insulin determined by an automated glucose level control system, the computer-implemented method comprising:
Dependencies are inferred from the claim text.